211 related articles for article (PubMed ID: 12047794)
1. Hypertriglyceridemia: a review beyond low-density lipoprotein.
Rapp RJ
Cardiol Rev; 2002; 10(3):163-72. PubMed ID: 12047794
[TBL] [Abstract][Full Text] [Related]
2. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
Grundy SM; Vega GL
Arch Intern Med; 1992 Jan; 152(1):28-34. PubMed ID: 1728925
[TBL] [Abstract][Full Text] [Related]
3. Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment.
Ferguson EE
Dis Mon; 2000 Jul; 46(7):421-503. PubMed ID: 10943222
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride as a risk factor for coronary artery disease.
Gotto AM
Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
[TBL] [Abstract][Full Text] [Related]
5. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
Grundy SM
Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
8. [Hypertriglyceridemia: danger for the arteries].
Chanu B
Presse Med; 1999 Nov; 28(36):2011-7. PubMed ID: 10599270
[TBL] [Abstract][Full Text] [Related]
9. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
10. The triglyceride connection in atherosclerosis.
Geurian K; Pinson JB; Weart CW
Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
[TBL] [Abstract][Full Text] [Related]
12. Triglycerides and coronary risk in women and the elderly.
LaRosa JC
Arch Intern Med; 1997 May; 157(9):961-8. PubMed ID: 9140266
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia: risks and perspectives.
Gotto AM
Am J Cardiol; 1992 Dec; 70(19):19H-25H. PubMed ID: 1466313
[TBL] [Abstract][Full Text] [Related]
14. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
15. Triglycerides as a risk factor for coronary artery disease.
Sprecher DL
Am J Cardiol; 1998 Dec; 82(12A):49U-56U; discussion 85U-86U. PubMed ID: 9915663
[TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemia. Examining its role in coronary heart disease.
Grundy SM
Postgrad Med; 1991 Oct; 90(5):201-2, 207-10. PubMed ID: 1924008
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol.
Szapary PO; Rader DJ
Curr Opin Pharmacol; 2001 Apr; 1(2):113-20. PubMed ID: 11714084
[TBL] [Abstract][Full Text] [Related]
18. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond.
Austin MA
Am J Epidemiol; 1989 Feb; 129(2):249-59. PubMed ID: 2643302
[TBL] [Abstract][Full Text] [Related]
19. Evidence that triglycerides are an independent coronary heart disease risk factor.
Cullen P
Am J Cardiol; 2000 Nov; 86(9):943-9. PubMed ID: 11053704
[TBL] [Abstract][Full Text] [Related]
20. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
Pennell P; Leclercq B; Delahunty MI; Walters BA
Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
